Atropos Health Partners with Databricks to Accelerate Evidence Generation and Advance Precision Medicine in Healthcare
Atropos Health utilizes Delta Sharing to access and link datasets across the Atropos Evidence™ Network, the largest federated data network in healthcare with over 300M patient records, including oncology data. Delta Sharing is Databricks' open source approach that enables customers to share live data across platforms, clouds and regions with strong security and governance. The new partnership combines Atropos Health's deep expertise in real-world evidence generation with Databricks' data intelligence expertise.
"Turning data into actionable evidence rapidly and accurately will accelerate the pace of innovation in healthcare,' said Dr. Brigham Hyde, CEO and co-founder at Atropos Health. "By responsibly and compliantly linking massive data sets in healthcare, we will drive not only better outcomes for patients, but a seamless user experience for healthcare researchers and providers."
'As we continue to help healthcare and life sciences organizations unlock the power of data intelligence, we're excited to welcome Atropos Health to the Built on Databricks Partner Program. Databricks is invested in bringing the best technology solutions to market for every industry, and this includes working with partners like Atropos Health,' said Michael Sanky, VP of Healthcare & Life Sciences GTM at Databricks. 'Atropos Health exemplifies the transformative potential of building on Databricks, and it's incredible to watch its adoption among healthcare and life sciences organizations who are excited to harness the full power of their data.'
Atropos Health recently launched Nodal Patient Deidentification and Query Time Interval Encoding across the GENEVA OS™ platform for members of the Atropos Evidence Network. The addition of Nodal Deidentification to the GENEVA OS platform enables users to fill data gaps in patients longitudinal records from participating Atropos Evidence Network sources, ensuring the most robust deidentified patient records while maintaining data possession and security.
Through this partnership, Atropos Health and Databricks are unlocking new opportunities in healthcare and life sciences by providing GENEVA OS™ and the Atropos Evidence™ Network as a single solution for data and analytics, combining Atropos Health's deep expertise in RWE with Databricks' data intelligence expertise. Customers rely on Atropos Health's portfolio of evidence-generation tools through the federated installation of GENEVA OS in their internal cloud data environment.
About Atropos Health
Atropos Health is the developer of GENEVA OS™, the operating system for rapid healthcare evidence across a robust network of real-world data. Healthcare and life science organizations work with Atropos Health to close evidence gaps from bench to bedside, improving individual patient outcomes with data-driven care, expediting research that advances the field of medicine, and more. We aim to transform healthcare with timely, relevant real-world evidence.
To learn more about Atropos Health, visit www.atroposhealth.com or connect through LinkedIn or follow on X (Twitter) @AtroposHealth.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
a day ago
- Business Upturn
Gluco6 Recognized for Strong Ingredient Transparency and OTC GLUT-4 Nutritional Support
AUSTIN, July 03, 2025 (GLOBE NEWSWIRE) — SECTION 1 – INTRODUCTION As interest in blood sugar health continues to expand across both clinical and non-clinical audiences, consumers are increasingly turning to nutrition science for new pathways to glucose management. Search trends show a growing curiosity in natural approaches to support healthy glucose levels, with a notable emphasis on metabolic flexibility, energy balance, and insulin sensitivity. In 2025, keywords such as 'natural blood sugar support,' 'GLUT-4 receptor,' and 'glucose stability' have gained momentum across digital wellness communities, reflecting a broader shift away from purely pharmaceutical solutions. The challenges of maintaining balanced blood sugar have become a frequent topic in wellness forums, with individuals expressing concerns around post-meal energy crashes, insulin spikes, and fatigue. At the same time, attention has turned to the underlying mechanisms—such as GLUT-4 receptor activity and metabolic responsiveness—as potential targets for support through diet and lifestyle. This shift has driven interest in ingredient-based interventions that are free of synthetic compounds, caffeine, or habit-forming additives. In response to this emerging demand, non-synthetic formulations with scientifically recognized plant-based ingredients have begun to gain visibility. Positioned at the intersection of transparency, innovation, and holistic health, Gluco6 represents part of this evolution in how the market approaches nutritional support for blood sugar metabolism. Further details about the formulation and ingredient sourcing can be found on the official informational platform SECTION 2 – PRODUCT/COMPANY UPDATE Gluco6, a plant-based glucose support formula, has released its latest ingredient update and formulation positioning for 2025, aligned with evolving consumer awareness around GLUT-4 receptor activity and non-synthetic pathways for managing blood sugar fluctuations. The formula, originally introduced as part of a broader push toward integrative glucose balance, now emphasizes its focus on GLUT-4 modulation—a mechanism supported by a growing body of nutritional and academic research. Unlike conventional formulations that often rely on stimulants or short-term glycemic suppression, Gluco6 positions itself as a wellness-aligned system built around the regulation of glucose transport pathways. At the center of this formula is Sukre™, a functional compound featured for its supportive interaction with GLUT-4 receptors, which play a critical role in the transport of glucose into muscle and fat cells. The 2025 update clarifies that Gluco6 is not intended to treat or cure any medical condition but serves as an informational approach to exploring non-clinical nutritional support. Developed without genetically modified ingredients, artificial stimulants, or synthetic additives, the Gluco6 formula also incorporates a blend of Mediterranean-sourced botanicals and micronutrients. The goal is to address consumer interest in formulations that prioritize purity, sustainability, and accessibility, without requiring prescription intervention. As of 2025, Gluco6 has expanded public-facing documentation to reinforce transparency in sourcing, ingredient disclosure, and alignment with trends in clean-label supplement development. The product update also includes a reaffirmation of the company's neutral wellness positioning—focusing on how nutritional strategies may support the body's natural glucose metabolism without implying outcomes or clinical effects. This update reflects Gluco6's continued alignment with current consumer behavior: seeking proactive, educational, and ingredient-based approaches to metabolic health. SECTION 3 – CONSUMER TREND OVERVIEW Throughout 2024 and into 2025, online search trends related to blood sugar balance have increasingly favored terms rooted in lifestyle wellness and plant-based support. Interest in phrases such as 'GLUT-4 function,' 'natural glucose regulation,' and 'non-synthetic blood sugar supplement' has reflected a cultural pivot toward metabolic autonomy—where individuals seek solutions that align with personal health goals without relying solely on pharmaceutical interventions. Public forums and wellness communities have observed a notable increase in discussions surrounding the mechanisms that influence glucose uptake, including insulin sensitivity, cellular transport pathways, and the role of nutrient timing. Central to these conversations is the GLUT-4 receptor, a protein that facilitates the movement of glucose into cells and has become a focal point for metabolic research and consumer inquiry alike. Gluco6's emergence into this environment corresponds with these heightened awareness levels. Rather than offering direct claims or prescriptive messaging, Gluco6 aligns with the growing preference for ingredient transparency and educational framing. Its inclusion of GLUT-4-supportive elements responds to the elevated attention this receptor has received in peer-reviewed studies and lifestyle research. In particular, consumers seeking to stabilize energy levels throughout the day—without the highs and lows associated with unregulated blood sugar—have shown interest in formulas that integrate metabolic adaptogens, antioxidant-rich botanicals, and bioavailable nutrients. These consumers often express a desire for plant-based formulations that can fit into daily routines without dependency or disruption. Gluco6's update positions the product within this narrative, offering a formulation that speaks to educated buyers interested in the intersection between nutritional science and non-clinical wellness. As digital content around metabolic flexibility and insulin response continues to rise, products that approach glucose management from a holistic, research-aware standpoint are seeing increased visibility in search engines and across peer-led platforms. To explore the full ingredient profile and supporting documentation, visit the official Gluco6 resource page. SECTION 4 – INGREDIENT SPOTLIGHT The Gluco6 formulation is centered around six ingredients selected for their alignment with contemporary wellness discussions surrounding non-synthetic blood sugar support. Each ingredient in the formula has been highlighted in academic literature or traditional nutrition systems for its potential to interact with metabolic processes in a non-clinical, supportive capacity. Sukre™ Sukre is positioned as a functional compound designed to work in harmony with the body's GLUT-4 transport mechanisms. As public interest grows around the role of cellular glucose transporters, Sukre has been referenced in emerging nutrition science as a compound that may complement healthy metabolic signaling. Gluco6 emphasizes Sukre as a core feature of its non-synthetic positioning, distinguishing it from traditional glucose-lowering agents that rely on acute suppression. TeaCrine® (Theacrine) Derived from Chinese tea leaves, TeaCrine is included in the Gluco6 formulation as a source of non-stimulant plant alkaloids. In various nutrition-focused publications, TeaCrine has been explored for its relationship with energy and focus without the involvement of caffeine. While not intended to produce clinical outcomes, its inclusion supports interest in plant-derived adaptogens. Gymnema Sylvestre A botanical with longstanding traditional use, Gymnema has been studied for its interaction with glucose perception and dietary habits. Often featured in educational content surrounding carbohydrate metabolism, Gymnema's presence in Gluco6 reflects a broader return to botanical heritage within modern supplement design. Chromium Recognized as an essential trace element, Chromium has been frequently mentioned in relation to insulin sensitivity and glycemic balance in nutrition science. Gluco6 includes Chromium in a bioavailable form, underscoring its role in contributing to foundational metabolic processes without overstating its role in therapeutic interventions. Cinnamon Bark Extract Used widely in culinary traditions and increasingly discussed in wellness circles, Cinnamon is incorporated in Gluco6 due to its relevance in insulin receptor support discussions. Its presence in the formula supports the theme of using accessible, food-sourced compounds within structured supplement protocols. Green Tea Extract Green Tea contributes both polyphenols and antioxidant compounds, often associated with general metabolic support. In Gluco6, it rounds out the ingredient profile by aligning with consumer interest in traditional, plant-based health strategies rooted in natural formulation integrity. SECTION 5 – USER JOURNEY / MARKET TONE Across digital forums and health-focused communities, the tone surrounding glucose management has increasingly moved away from urgency-based problem-solving and toward long-term lifestyle integration. In this context, Gluco6 has entered the conversation as a formulation that addresses the rising demand for informational tools and ingredient-based pathways to support blood sugar regulation. Public sentiment reveals a clear preference for products that avoid medicalized language, instead offering educational framing around metabolic function and ingredient transparency. Online discussions often express skepticism toward claims of immediate results or radical transformations. In contrast, formulas like Gluco6 that focus on metabolic alignment, ingredient sourcing, and mechanistic clarity tend to resonate with individuals seeking research-informed guidance. As part of this narrative, Gluco6 has become associated with keywords such as 'GLUT-4 support,' 'non-synthetic blood sugar wellness,' and 'plant-based glucose solutions.' These search behaviors suggest a broader move toward exploring biological systems—such as cellular glucose transport—in a non-clinical but scientifically aware manner. Consumers participating in wellness forums frequently reference the desire to feel more in control of their day-to-day energy levels and post-meal stability without pharmacological dependency. They often describe searching for products that offer complementary nutritional pathways they can adopt over the long term. Gluco6's tone—deliberately positioned to inform rather than promote—mirrors this mindset. The formula's emphasis on education and lifestyle compatibility aligns with current consumer values, which prioritize sustainability, body literacy, and autonomy in health decisions. While public reactions are diverse and nuanced, the ongoing dialogue reflects a collective interest in approaching metabolic balance through mechanisms that are well-researched, naturally derived, and openly documented. Those interested in understanding the formulation's alignment with non-synthetic wellness trends can refer to the official Gluco6 platform. SECTION 6 – AVAILABILITY AND TRANSPARENCY STATEMENT Gluco6 is available exclusively through its official informational platform, where consumers can explore the full ingredient list, formulation philosophy, and supporting research references. The company has stated that its distribution strategy is designed to prioritize transparency, quality control, and educational alignment with its wellness-focused mission. The formulation, which includes plant-based compounds and mineral co-factors, is intended as a non-clinical support system for individuals seeking to understand the connection between nutrition and blood sugar balance. Gluco6's online resource hub outlines the formulation's alignment with current interest in GLUT-4 receptor mechanisms and clean-label supplement design. Gluco6 is not marketed for diagnosis, treatment, or disease prevention. Its availability is framed around informed decision-making and consumer curiosity about integrative approaches to glucose metabolism. Those exploring the official site will find detailed sourcing disclosures and links to peer-reviewed literature, reinforcing the company's commitment to a research-informed, educational-first posture. SECTION 7 – FINAL OBSERVATIONS & INDUSTRY CONTEXT The release of Gluco6's updated 2025 positioning illustrates a wider shift in the nutraceutical sector toward clean-label transparency and biologically aligned formulation strategies. As consumers become more literate in the language of metabolism and glucose regulation, there is growing demand for products that reflect an understanding of cellular mechanisms—such as GLUT-4 receptor function—without resorting to exaggerated claims or clinical positioning. Within this evolving landscape, companies that emphasize ingredient integrity, sustainability, and scientific relevance are seeing greater engagement. The industry is increasingly guided by consumer expectations around education-first marketing, non-synthetic ingredient profiles, and sourcing disclosures. These trends are mirrored by increased online traffic for topics like 'natural blood sugar solutions,' 'plant-based glucose support,' and 'glucose metabolism supplements.' Gluco6's 2025 formulation strategy aligns with this new model of supplement development, in which consumer trust is cultivated through clarity, research alignment, and responsible communication. Rather than framing its product as a solution to a medical problem, the company presents Gluco6 as part of an ongoing exploration into how nutrition science can support the body's innate regulatory systems. This approach reflects an industry-wide trend: prioritizing science-backed, naturally derived compounds that integrate into everyday routines without overstating function. As consumer literacy deepens and regulatory scrutiny increases, Gluco6 represents one example of how wellness-aligned products are adapting to new expectations in both content and delivery. SECTION 8 – PUBLIC COMMENTARY THEME SUMMARY In ongoing public forums and digital health communities, Gluco6 has emerged as part of a broader conversation around non-synthetic blood sugar support, drawing a range of responses that highlight both interest and scrutiny. Among recurring discussion points, many participants have noted the formula's focus on GLUT-4 receptor pathways as a distinguishing element, particularly given the increasing awareness around cellular glucose transport in metabolic wellness contexts. Some users have expressed curiosity about the inclusion of lesser-known compounds such as Sukre™, citing interest in how this ingredient fits into emerging nutritional science. Others have pointed to the presence of familiar ingredients—like Cinnamon, Chromium, and Green Tea—as aligning with existing wellness preferences for natural, food-based compounds. A recurring theme in positive commentary centers around the non-stimulant profile of the formula. Consumers who prioritize energy regulation without caffeine or dependency have referenced this as a potential alignment with their values. Transparency in ingredient sourcing and documentation has also been identified as a favorable trait, especially among those seeking clarity in wellness product selection. At the same time, some public sentiment remains cautiously observational. Individuals exploring glucose support options often raise questions about long-term integration, expected timelines for perceived effects, and how formulas like Gluco6 should be interpreted within the context of dietary and lifestyle change. This underscores a broader pattern in health discussions—where skepticism and education coexist as consumers navigate an increasingly complex wellness market. These public conversations reflect a nuanced reception that values transparency, biological alignment, and clear communication. While interest in the GLUT-4 mechanism is growing, the broader dialogue continues to emphasize the importance of framing nutritional products as part of a holistic, informed approach to metabolic balance. ABOUT THE COMPANY Gluco6 was developed as part of a broader initiative to provide consumers with transparent, research-aligned nutritional formulas focused on metabolic wellness. The company's mission is to support individuals seeking non-synthetic pathways to manage energy, blood sugar stability, and overall well-being through informed supplementation. By emphasizing ingredient traceability, scientific context, and clean-label formulation practices, Gluco6 contributes to a growing category of supplements positioned at the intersection of education and daily health support. The company does not offer medical advice or therapeutic services and does not market its products for the treatment, prevention, or diagnosis of disease. Its offerings are intended for informational and wellness-aligned purposes only. CONTACT: Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Business Wire
a day ago
- Business Wire
QT Imaging to Hold Virtual 2025 Annual Meeting of Stockholders on August 19
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (OTCQB: QTIH), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced that its 2025 Annual Meeting of Stockholders will be held as a virtual meeting on Tuesday, August 19, 2025, at 1:00 p.m. EDT (10:00 a.m. PDT). Stockholders of record at the close of business on July 16, 2025 shall be entitled to vote at the 2025 Annual Meeting. Information about the virtual meeting webcast and instructions for how stockholders can participate in the 2025 Annual Meeting will be included in the definitive proxy statement to be filed with the Securities and Exchange Commission and will be available on the "Investors" section of QT Imaging's website at About QT Imaging Holdings, Inc. QT Imaging Holdings, Inc. is a public (OTCQB: QTIH) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient's experience. For more information on QT Imaging Holdings, Inc., please visit the company's website at Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as 'will,' and 'expect,' or the negative thereof or comparable terminology, and include (without limitation) statements regarding the date of its annual meeting of stockholders. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. These risks include, but are not limited to: research results from the use of the QT Imaging Breast Acoustic CT Scanner, the ability of QT Imaging Holdings to sell and deploy the QT Imaging Breast Acoustic CT Scanner, the ability to extend product offerings into new areas or products, the ability to commercialize technology, unexpected occurrences that deter the full documentation and 'bring to market' plan for products, trends and fluctuations in the industry, changes in demand and purchasing volume of customers, unpredictability of suppliers, the ability to attract and retain qualified personnel and the ability to move product sales to production levels. Additional factors that could cause actual results to differ are discussed under the heading 'Risk Factors' and in other sections of QT Imaging Holding's filings with the SEC, and in its other current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to QT Imaging Holdings as of the date hereof, and QT Imaging Holdings assumes no obligation to update any forward-looking statement.
USA Today
2 days ago
- USA Today
AI Ultra-HD Birdwatching: Kiwibit Turns Your Home into a Nature Theater
Have you ever waited days or even weeks for the perfect visitor? That elegant, delicate little bird, dazzling like a streak of blue lightning. Finally, your smart bird feeder buzzes—an Indigo Bunting has arrived. You scramble to capture the moment, only to discover the feeder mislabeled the bird as a sparrow, the video is blurry, and the battery died right after. It's hard to put into words how disappointing this is. For many families hoping to bring nature closer, the dream is to have a bird feeder that's both effortless and enjoyable to use as promised. But in reality, the system misidentifies common birds, cameras miss the clarity to distinguish plumage and detail, and battery life proves too short for real daily use. It's these frustrations that led Kiwibit to create Beako™—a device built not just for birds, but for the people who care about them. At the heart of Beako™ is an AI-powered ultra-high-definition 4K camera, and every step it takes is impressive. The moment a bird touches down, the wide-angle lens wakes up silently. A glint of iridescent feathers, a shared moment over seeds, even an aerial squabble—everything is captured in striking detail, turning your backyard into a front-row seat to nature's theater. Worried you might miss it? You won't. Beako™'s KeyShot feature records highlights automatically, so you never miss a moment worth saving and sharing. Its AI, trained on data from over 10,000 bird species, accurately tags each visitor and sends a gentle notification to your phone, complete with species facts and photos. Meanwhile, the smart detection system quietly screens intruders like squirrels, keeping the stage reserved for your feathered guests. Every aspect of Beako™ is thoughtfully designed with real-world use in mind. Dual food chambers with a 1.5-liter total capacity make refilling simple and varied. The easy-to-clean tray detaches in seconds and is fully washable. The weatherproof design is rated IP65 and operates in temperatures as low as -4°F and as high as 122°F, while the solar-powered battery ensures weeks of uninterrupted use. The setup process is quick and intuitive. The app walks users through installation, Wi-Fi connection, and preferences like notification timing or privacy modes. What really sets Beako™ apart isn't just the technology. It's how that technology fits into your day. It doesn't demand your attention. It enhances your awareness. It turns a backyard into a place of daily wonder that sparks curiosity in kids, offers adults a moment of stillness amid the noise of modern life, and most importantly, brings generations together. Whether you're a seasoned birder or just starting out, Beako™ transforms simple backyard visits into shared family moments. For parents looking to teach kids about local wildlife, or seniors enjoying the rhythms of nature from the porch, Beako™ offers a lens through which to see the world a little more clearly. Beako™ also makes for a thoughtful gift which carries meaning beyond the packaging. For birthdays, holidays, or housewarming occasions, it introduces a new kind of present: an invitation to connect with nature, to learn something new each day, and to build habits that enrich family life. Reviews from early users speak to its everyday impact. 'It's part of our morning routine now,' wrote one user from the U.S. 'Coffee, toast, and seeing who showed up on Beako™ overnight.' Another called it 'a way to slow down and tune in, without needing to leave home.' Beako™ is available now at and with special Prime Day deals just around the corner. For those looking to surprise a loved one, this is not to be missed.
